Schedule 13G ownership disclosure

Achieve Life Sciences Inc

Common Stock, par value $0.001 per share · CUSIP: 004468500

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Contrarian Alpha, LP

    Shares: 550,000 · Class: 1.1%

  • Contrarian Achieve SPV, LP

    Shares: 1,978,377 · Class: 3.8%

  • Contrarian Achieve GP LLC

    Shares: 1,978,377 · Class: 3.8%

  • Contrarian Alpha GP, LLC

    Shares: 550,000 · Class: 1.1%

  • Contrarian Alpha Management, LLC

    Shares: 550,000 · Class: 1.1%

  • Parker Quillen

    Shares: 2,528,377 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-25-001417
Form type
SCHEDULE 13G/A
Filer
ACHIEVE LIFE SCIENCES, INC.
CIK
CIK 949858
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub